Research Applications Gastrointestinal: Ulcer repair, gut lining integrity modelling, and IBD pathway research
Causes of deficiency include: Insufficient intake Malabsorption in gastrointestinal diseases Increased requirements during pregnancy Antiepileptic drugs (phenytoin, primidone, phenobarbital) may decrease FA absorption, presumably by inhibiting the formation of monoglutamine- folic acid Inhibition of dihydro-folic acid reductase (e.g., by methotrexate) depresses the formation of the active species, tetrahydro-folic acid Symptoms of deficiency are: megaloblastic anemia mucosal damage Therapy of folic acid deficiency Therapy consists in oral administration of Folic Acid or folinic acid when deficiency is caused by inhibitors of dihydroFAreductase
Some speakers during the open public hearing suggested that adding these materials to the list could create safer access and more oversight for materials that will likely continue to be used
That places BPC-157 in the same regulatory bucket as other unapproved research peptides like TB-500 (thymosin beta-4 fragment) and GHK-Cu
Contaminant screening The company claims screening for heavy metals, microbials, and common contaminants
